Literature DB >> 10644626

Nitric oxide release and contractile properties of skeletal muscles from mice deficient in type III NOS.

W Hirschfield1, M R Moody, W E O'Brien, A R Gregg, R M Bryan, M B Reid.   

Abstract

Skeletal muscle constitutively expresses both the type I (neuronal) and type III (endothelial) isoforms of nitric oxide synthase (NOS). We tested the functional importance of type III NOS using skeletal muscles with similar levels of type III NOS expression (diaphragm and soleus) from wild-type, heterozygous, and type III NOS-deficient littermate mice. Muscles were incubated at 37 degrees C in Krebs-Ringer solution. NO accumulation in the medium was measured by chemiluminescence; force-frequency and fatigue characteristics were measured using direct electrical stimulation. Diaphragm and soleus released NO at similar rates during passive incubation; these rates increased during active contraction. NO release by type III NOS-deficient muscle was not different from that of wild-type muscle under any condition tested. Force-frequency and fatigue characteristics also were unaffected by genotype. Because type III NOS deficiency did not alter function, we conclude that NO effects previously observed in wild-type muscle are likely to be mediated by type I NOS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644626     DOI: 10.1152/ajpregu.2000.278.1.R95

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  21 in total

1.  Effects of neuronal nitric oxide synthase inhibition on resting and exercising hindlimb muscle blood flow in the rat.

Authors:  Steven W Copp; Daniel M Hirai; Peter J Schwagerl; Timothy I Musch; David C Poole
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

Review 2.  Reactive oxygen species and redox-regulation of skeletal muscle adaptations to exercise.

Authors:  Malcolm J Jackson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 3.  The multiple actions of NO.

Authors:  Yuansheng Gao
Journal:  Pflugers Arch       Date:  2009-12-19       Impact factor: 3.657

4.  Antioxidant treatments do not improve force recovery after fatiguing stimulation of mouse skeletal muscle fibres.

Authors:  Arthur J Cheng; Joseph D Bruton; Johanna T Lanner; Håkan Westerblad
Journal:  J Physiol       Date:  2014-12-11       Impact factor: 5.182

5.  Impaired vasomodulation is associated with reduced neuronal nitric oxide synthase in skeletal muscle of ovariectomized rats.

Authors:  Paul J Fadel; Weiying Zhao; Gail D Thomas
Journal:  J Physiol       Date:  2003-03-28       Impact factor: 5.182

6.  Influence of dietary nitrate supplementation on human skeletal muscle metabolism and force production during maximum voluntary contractions.

Authors:  Jonathan Fulford; Paul G Winyard; Anni Vanhatalo; Stephen J Bailey; Jamie R Blackwell; Andrew M Jones
Journal:  Pflugers Arch       Date:  2013-01-26       Impact factor: 3.657

7.  Effects of neuronal nitric oxide synthase inhibition on microvascular and contractile function in skeletal muscle of aged rats.

Authors:  Daniel M Hirai; Steven W Copp; Clark T Holdsworth; Scott K Ferguson; Timothy I Musch; David C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-24       Impact factor: 4.733

Review 8.  Reactive oxygen species: impact on skeletal muscle.

Authors:  Scott K Powers; Li Li Ji; Andreas N Kavazis; Malcolm J Jackson
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

9.  Nitric oxide is required for the insulin sensitizing effects of contraction in mouse skeletal muscle.

Authors:  Xinmei Zhang; Danielle Hiam; Yet-Hoi Hong; Anthony Zulli; Alan Hayes; Stephen Rattigan; Glenn K McConell
Journal:  J Physiol       Date:  2017-11-21       Impact factor: 5.182

Review 10.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.